Will West

Executive Chairman & Board Member

Will co-founded CellCentric, and was appointed Executive Chairman in September 2014.

Will gained his PhD in 1991, in Immunology and Virology sponsored by Unilever (UniPath), before holding a post-doctoral position at the National Institute of Biological Standards and Control (NIBSC). He went on to Procter & Gamble Healthcare, where he was responsible for clinical development in a number of therapeutic areas, including respiratory and GI. He led and delivered programmes throughout Europe, the Americas, South Africa and China.

Will is also President & CEO of Cancer Targeting Systems (CTS) Inc., a cancer imaging and therapeutic business from Johns Hopkins School of Medicine. In 2011 he was appointed by the Science Minister to the Council of the BBSRC, the UK’s leading funder of bioscience research. In 2012 Will was elected to the Board of the BioIndustry Association and sits on both the Executive and Audit Committees. He holds a Masters degree in Clinical Research as well as an MBA from London Business School.